Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography
Summary
BILTHOVEN, Netherlands--(BUSINESS WIRE)--Avania, the leading, global medical technology contract research organization (CRO) and advisory services partner, today announced its acquisition of Anagram. Anagram is a perfect fit for Avania, enabling the company to increase CRO business in Spain and providing greater access to a growing MedTech country. Avania customers will benefit from an expanded geographic footprint and an enhanced roster of subject matter experts concentrated on areas of key therapeutic expertise. “It will provide us with a significant footprint in Spain and Southern Europe and further strengthen our cardiovascular and neurology franchises while expanding our oncology capabilities.” Avania is the leading global MedTech clinical research organization and advisory partner with a focus on medical devices, diagnostics/IVDs, and digital health. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being.